Quality Management

Regen Lab Quality System Management ensures the consistency of our products quality at every stage, from design to production and distribution

Quality Product & Management | Leading the Future of Regenerative Medicine

At Regen Lab, we are dedicated to advancing regenerative medicine through the development, manufacture, and distribution of medical devices.

Our commitment to quality and safety is at the core of our operations, ensuring the highest standards in patient care and user safety.

 

Our Commitment to Quality

Compliance and Standards: Our Quality System Management follows the European regulation requirement according to (EU) MDR 2017/745 and European Directive 93/42EEC for product still on the transition, the 21 CFR 820 and other applicable regulatory requirements. We operate within the ISO 13485 framework, ensuring our management systems meet rigorous medical device manufacturing requirements. 

Innovative Production Facilities: We have established state-of-the-art production aera equipped with high technologies. This ensures the manufacture of reliable, high-quality devices while maintaining a focus on employee well-being.

Quality System Management

Our Quality System Management ensures the consistency of our products quality at every stage, from design to production and distribution in accordance to standard ISO 13485 by minimised risks, enhances patient safety and performance

CERTIFICATIONS

CERTIFICATIONS

The Future of Regenerative Medicine

Advanced Production Facility

Our production facility demonstrated our commitment to quality and innovation. Our infrastructure supports efficient manufacturing processes. We prioritize an environmental control, maintaining stringent atmospheric controls in our production aeras to meet the highest standards of medical device manufacturing.

Quality System Management

At Regen Lab, consistency in product quality is paramount. Our Quality System Management ensures every device meets rigorous standards. We adhere to the ISO 13485 standard, integrating essential requirements into our management systems to ensure excellence in medical device manufacturing.

Regulatory Compliance

Regen Lab follows a rigorous approach to regulatory compliance and Quality System Management. We operate within the framework of ISO 13485 standard, ensuring that our management systems meet the highest standards required for medical device manufacturers. Additionally, our quality system complies with the European Regulation 2017/745 on medical devices, underscoring our dedication to quality and safety.

Since 2003, Regen Lab SA has been committed to the development of a unique expertise for the design and manufa​cturing of high-quality medical devices.

Copyright © 2024 All rights reserved.

About Us

Since 2003, Regen Lab SA has specialized in designing and manufacturing high-quality medical devices for cell therapies and the preparation of autologous platelet-rich plasma (PRP) from the patient's own blood for bedside procedures.

Milestones

2003 - Foundation
2010 - RegenKit first approval in bone graft
2013 - A new state-of-theart laboratory in Lausanne
2014 - Cellular Matrix first approval
2015 - Launch of Cellular Matrix in Europe

Vision

Founded in 2003, Regen Lab has become a global reference thanks to its commitment to innovation, quality, and the effectiveness of its therapeutic solutions. Here’s how we have transformed the medical landscape over the past two decades.

RegenPRP™

RegenPRP™ est un traitement médical qui utilise le plasma riche en plaquettes provenant du sang du patient pour améliorer et la régénération tissulaire.

RegenPRP™ - HA

Cellular Matrix® est un traitement innovant combinant le plasma riche en plaquettes (PRP) et l'acide hyaluronique pour améliorer la régénération tissulaire et la guérison.

RegenPRP™ - ATS

RegenPRP™ combiné avec ATS (Autologous Thrombin Serum) est une approche avancée pour la régénération tissulaire qui utilise le plasma riche en plaquettes (PRP) enrichi en thrombine autologue pour maximiser les effets de guérison.

RegenExtracell®

RegenExtracell est un traitement innovant axé sur la régénération tissulaire qui utilise une matrice extracellulaire enrichie en plasma riche en plaquettes (PRP).

Hyaluronic Acid

L'acide hyaluronique est une substance naturellement présente dans le corps humain, particulièrement dans la peau, les articulations et les yeux.

Regulatory

Manufacturers of medical devices based outside the EU must designate an Authorized Representative (EC-REP) established within the EU in order to meet the CE requirements for placing medical devices on the EU market.

Quality Management

Regen Lab Quality System Management ensures the consistency of our products quality in total GMP compliance.

Our production facility rooms atmosphere is monitored to satisfy non-pyrogenic medical devices manufacturing.

Patents

As a leader in the PRP&HA regenerative field and as an innovation-driven company, Regen Lab SA has devoted important resources since 2004 to put on the market pioneering and diversified products constituting a complete set of tools/technologies for the medical community.

Safety & Privacy policies

WEBSITE PRIVACY NOTICE

We recommend you to acquaint yourself with the full content of our Privacy Policy.